HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetics News In Brief: ECHA Makes Non-Confidential REACH Data More Accessible

This article was originally published in The Rose Sheet

Executive Summary

Stakeholders can now download a database of key study results for nearly 15,000 chemicals registered under the EU’s REACH regulation, benefiting from streamlined access to information that previously was more of a chore to compile, the European Chemicals Agency says. More news in brief.

You may also be interested in...



ECHA Refers 2018 REACH Registrants To New Data Search Tools, Funding Options

The European Chemicals Agency is promoting a searchable list of lead registrants, accessible through a new interactive infographic, among other tools and resources available to support industry compliance, particularly among SMEs, as the 2018 REACH registration deadline draws closer.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation

Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel